Clinical Trial: Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Non-small Cell Lung Cancer
Study Type: INTERVENTIONAL
Official Title: Assessing the Immunomodulatory Effects of Pharmacologic Ascorbate With Durvalumab (MEDI 4736) in Non-Small Cell Lung Cancer: A Window of Opportunity Trial
Brief Summary:
This is a descriptive, proof of concept, open-label, randomized, 3-arm, window of opportunity trial to evaluate the immunomodulatory role of pharmacological ascorbate with Durvalumab
Read more